PREVALENT integrates essential pre-clinical research platforms ranging from pre-clinical evaluations of drugs, disease modelling using precision animal models, medicinal chemistry, and the assessment of environmental factors to state-of-the-art in silico modelling approaches.
Unique is the conversion of extensive experimental pre-clinical data into in silico interactive models supporting research and pharma communities to efficiently develop novel or improved therapies, foresee adverse effects, explore repurposing possibilities, and to identify long-term environmental impacts.
Our goal is to establish an integrative Research Infrastructure providing highly standardised, large-scale platforms for pre-clinical and environmental evaluations, and to create an in silico portal for virtual gene-drug-environment actions, as a unique global resource underpinning in silico- and environmental medicine and innovative therapeutic developments.
